AU Stock MarketDetailed Quotes

IXC Invex Therapeutics Ltd

Watchlist

0.076
0.0000.00%

20min DelayMarket Closed Nov 21 13:27 AET

5.71MMarket Cap-3454P/E (Static)

Invex Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2024

(Q4)Jun 30, 2024

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(FY)Jun 30, 2022

(Q4)Jun 30, 2022

(FY)Jun 30, 2021

(Q4)Jun 30, 2021

(FY)Jun 30, 2020

(Q4)Jun 30, 2020

Assets

Current assets

Cash, cash equivalents and short term investments

-73.19%6.03M

-23.41%22.47M

-10.32%29.34M

24.39%32.72M

--26.3M

-Cash and cash equivalents

-73.19%6.03M

-23.41%22.47M

-10.32%29.34M

24.39%32.72M

--26.3M

Receivables

-71.52%94.98K

128.92%333.57K

587.37%145.72K

-81.86%21.2K

--116.88K

-Other receivables

-71.52%94.98K

128.92%333.57K

587.37%145.72K

-81.86%21.2K

--116.88K

Total current assets

-73.16%6.12M

-22.66%22.8M

-9.93%29.49M

23.92%32.74M

--26.42M

Non current assets

Total non current assets

--0

Total assets

-73.16%6.12M

-22.66%22.8M

-9.93%29.49M

23.92%32.74M

--26.42M

Liabilities

Current liabilities

Payables

-72.55%431.63K

56.58%1.57M

52.47%1M

-7.62%658.61K

--712.95K

-accounts payable

-99.51%5.6K

723.58%1.14M

1,124.55%138.78K

-62.72%11.33K

--30.4K

-Other payable

-0.79%426.03K

-50.38%429.42K

33.70%865.44K

-5.17%647.28K

--682.55K

Other current liabilities

----

--1.3M

Current liabilities

-72.55%431.63K

56.58%1.57M

52.47%1M

-67.32%658.61K

--2.02M

Non current liabilities

Total non current liabilities

--0

Total liabilities

-72.55%431.63K

56.58%1.57M

52.47%1M

-67.32%658.61K

--2.02M

Shareholders'equity

Share capital

-38.45%22.41M

0.00%36.41M

34.78%36.41M

--27.02M

-common stock

-38.45%22.41M

0.00%36.41M

34.78%36.41M

--27.02M

Retained earnings

-9.34%-19.22M

-78.84%-17.58M

-67.27%-9.83M

-63.58%-5.88M

---3.59M

Gains losses not affecting retained earnings

4.17%2.5M

26.38%2.4M

23.05%1.9M

57.75%1.54M

--977.24K

Total stockholders'equity

-73.21%5.69M

-25.45%21.23M

-11.22%28.48M

31.46%32.08M

--24.4M

Total equity

-73.21%5.69M

-25.45%21.23M

-11.22%28.48M

31.46%32.08M

--24.4M

Accounting Standards

US-GAAP

	(FY)Jun 30, 2024	(Q4)Jun 30, 2024	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(FY)Jun 30, 2022	(Q4)Jun 30, 2022	(FY)Jun 30, 2021	(Q4)Jun 30, 2021	(FY)Jun 30, 2020	(Q4)Jun 30, 2020
Assets
Current assets
Cash, cash equivalents and short term investments	-73.19%6.03M	-73.19%6.03M	-23.41%22.47M	-23.41%22.47M	-10.32%29.34M	-10.32%29.34M	24.39%32.72M	24.39%32.72M	--26.3M	--26.3M
-Cash and cash equivalents	-73.19%6.03M	-73.19%6.03M	-23.41%22.47M	-23.41%22.47M	-10.32%29.34M	-10.32%29.34M	24.39%32.72M	24.39%32.72M	--26.3M	--26.3M
Receivables	-71.52%94.98K	-71.52%94.98K	128.92%333.57K	128.92%333.57K	587.37%145.72K	587.37%145.72K	-81.86%21.2K	-81.86%21.2K	--116.88K	--116.88K
-Other receivables	-71.52%94.98K	-71.52%94.98K	128.92%333.57K	128.92%333.57K	587.37%145.72K	587.37%145.72K	-81.86%21.2K	-81.86%21.2K	--116.88K	--116.88K
Total current assets	-73.16%6.12M	-73.16%6.12M	-22.66%22.8M	-22.66%22.8M	-9.93%29.49M	-9.93%29.49M	23.92%32.74M	23.92%32.74M	--26.42M	--26.42M
Non current assets
Total non current assets	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total assets	-73.16%6.12M	-73.16%6.12M	-22.66%22.8M	-22.66%22.8M	-9.93%29.49M	-9.93%29.49M	23.92%32.74M	23.92%32.74M	--26.42M	--26.42M
Liabilities
Current liabilities
Payables	-72.55%431.63K	-72.55%431.63K	56.58%1.57M	56.58%1.57M	52.47%1M	52.47%1M	-7.62%658.61K	-7.62%658.61K	--712.95K	--712.95K
-accounts payable	-99.51%5.6K	-99.51%5.6K	723.58%1.14M	723.58%1.14M	1,124.55%138.78K	1,124.55%138.78K	-62.72%11.33K	-62.72%11.33K	--30.4K	--30.4K
-Other payable	-0.79%426.03K	-0.79%426.03K	-50.38%429.42K	-50.38%429.42K	33.70%865.44K	33.70%865.44K	-5.17%647.28K	-5.17%647.28K	--682.55K	--682.55K
Other current liabilities	----	----	----	----	----	----	----	----	--1.3M	--1.3M
Current liabilities	-72.55%431.63K	-72.55%431.63K	56.58%1.57M	56.58%1.57M	52.47%1M	52.47%1M	-67.32%658.61K	-67.32%658.61K	--2.02M	--2.02M
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	-72.55%431.63K	-72.55%431.63K	56.58%1.57M	56.58%1.57M	52.47%1M	52.47%1M	-67.32%658.61K	-67.32%658.61K	--2.02M	--2.02M
Shareholders'equity
Share capital	-38.45%22.41M	-38.45%22.41M	0.00%36.41M	0.00%36.41M	0.00%36.41M	0.00%36.41M	34.78%36.41M	34.78%36.41M	--27.02M	--27.02M
-common stock	-38.45%22.41M	-38.45%22.41M	0.00%36.41M	0.00%36.41M	0.00%36.41M	0.00%36.41M	34.78%36.41M	34.78%36.41M	--27.02M	--27.02M
Retained earnings	-9.34%-19.22M	-9.34%-19.22M	-78.84%-17.58M	-78.84%-17.58M	-67.27%-9.83M	-67.27%-9.83M	-63.58%-5.88M	-63.58%-5.88M	---3.59M	---3.59M
Gains losses not affecting retained earnings	4.17%2.5M	4.17%2.5M	26.38%2.4M	26.38%2.4M	23.05%1.9M	23.05%1.9M	57.75%1.54M	57.75%1.54M	--977.24K	--977.24K
Total stockholders'equity	-73.21%5.69M	-73.21%5.69M	-25.45%21.23M	-25.45%21.23M	-11.22%28.48M	-11.22%28.48M	31.46%32.08M	31.46%32.08M	--24.4M	--24.4M
Total equity	-73.21%5.69M	-73.21%5.69M	-25.45%21.23M	-25.45%21.23M	-11.22%28.48M	-11.22%28.48M	31.46%32.08M	31.46%32.08M	--24.4M	--24.4M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data